COLON-MD: Colon Cancer Longitudinal Study

Part of paid clinical trials in Temple, Texas.

Sponsor
Baylor Research Institute
Study ID
NCT04751448
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 79 Years
Healthy Volunteers
Not accepted

Study Details

The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.

Key Dates

Start date
Feb 1, 2021
Status verified
Jan 2026
Primary completion
Jun 1, 2026
Completion
Jun 1, 2026

Study Design

Enrollment
11 participants (estimated)

Arms

  • Arm: Observational
    All patients going on study will be put in the observational grouping for blood and tissue collection with option for stool collection.

Primary Outcome Measure

Microbiome-Based Prediction of Chemotherapy-induced Diarrhea in Colon Cancer [ Time Frame: 3 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Baylor Research InstituteTempleTexas76508
Karen Templeton
[email protected]
254-724-1377
Lisa Woytek
[email protected]
254-724-1054
Lucas Wong, MD (PRINCIPAL_INVESTIGATOR)
Hitesh Singh, MD (SUB_INVESTIGATOR)
Juddi Yeh, MD (SUB_INVESTIGATOR)
Christal Murray, MD (SUB_INVESTIGATOR)

Find similar trials in Temple, TX

By condition
Colorectal cancer
By specialty
OncologyGI oncology
By research site
Baylor Research Institute· Temple, TX

Related Studies